These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 38992691)
1. Uncovering the role of ferroptosis in Bietti crystalline dystrophy and potential therapeutic strategies. Shen C; Yang Q; Chen K; Ma H; Wang X; Tong J; Shen Y; Cui H Cell Commun Signal; 2024 Jul; 22(1):359. PubMed ID: 38992691 [TBL] [Abstract][Full Text] [Related]
2. PSCs Reveal PUFA-Provoked Mitochondrial Stress as a Central Node Potentiating RPE Degeneration in Bietti's Crystalline Dystrophy. Zhang Z; Yan B; Gao F; Li Q; Meng X; Chen P; Zhou L; Deng W; Li C; Xu W; Han S; Feng H; Li Y; Chen J; Yin Z; Liao C; Tse HF; Xu A; Lian Q Mol Ther; 2020 Dec; 28(12):2642-2661. PubMed ID: 32755565 [TBL] [Abstract][Full Text] [Related]
3. AAV-mediated gene-replacement therapy restores viability of BCD patient iPSC derived RPE cells and vision of Cyp4v3 knockout mice. Jia R; Meng X; Chen S; Zhang F; Du J; Liu X; Yang L Hum Mol Genet; 2023 Jan; 32(1):122-138. PubMed ID: 35925866 [TBL] [Abstract][Full Text] [Related]
4. Accumulation of Lipid Droplets in a Novel Bietti Crystalline Dystrophy Zebrafish Model With Impaired PPARα Pathway. Gao P; Jia D; Li P; Huang Y; Hu H; Sun K; Lv Y; Chen X; Han Y; Zhang Z; Ren X; Wang Q; Liu F; Tang Z; Liu M Invest Ophthalmol Vis Sci; 2022 May; 63(5):32. PubMed ID: 35616930 [TBL] [Abstract][Full Text] [Related]
5. In vivo genome editing via CRISPR/Cas9-mediated homology-independent targeted integration for Bietti crystalline corneoretinal dystrophy treatment. Meng X; Jia R; Zhao X; Zhang F; Chen S; Yu S; Liu X; Dou H; Feng X; Zhang J; Wang N; Xu B; Yang L Nat Commun; 2024 May; 15(1):3773. PubMed ID: 38710738 [TBL] [Abstract][Full Text] [Related]
6. Reduction of lipid accumulation rescues Bietti's crystalline dystrophy phenotypes. Hata M; Ikeda HO; Iwai S; Iida Y; Gotoh N; Asaka I; Ikeda K; Isobe Y; Hori A; Nakagawa S; Yamato S; Arita M; Yoshimura N; Tsujikawa A Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3936-3941. PubMed ID: 29581279 [TBL] [Abstract][Full Text] [Related]
7. Evaluating precision medicine approaches for gene therapy in patient-specific cellular models of Bietti crystalline dystrophy. Li Y; Yang RR; Li YS; Hsu CW; Jenny LA; Kong Y; Ruan MZ; Sparrow JR; Tsang SH JCI Insight; 2024 Aug; 9(16):. PubMed ID: 39171529 [TBL] [Abstract][Full Text] [Related]
8. Genetics of Bietti Crystalline Dystrophy. Ng DS; Lai TY; Ng TK; Pang CP Asia Pac J Ophthalmol (Phila); 2016; 5(4):245-52. PubMed ID: 27228076 [TBL] [Abstract][Full Text] [Related]
9. Detailed functional and structural phenotype of Bietti crystalline dystrophy associated with mutations in CYP4V2 complicated by choroidal neovascularization. Fuerst NM; Serrano L; Han G; Morgan JI; Maguire AM; Leroy BP; Kim BJ; Aleman TS Ophthalmic Genet; 2016 Dec; 37(4):445-452. PubMed ID: 27028354 [TBL] [Abstract][Full Text] [Related]
10. Crystalline Hepatopathy Associated With Bietti Crystalline Dystrophy: A Striking Manifestation of Disordered Fatty Acid Metabolism. Dulken BW; Bahceci D; Leung LS; Mahajan VB; Choi WT; Tan SY Am J Surg Pathol; 2024 Sep; 48(9):1138-1145. PubMed ID: 38802997 [TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of a murine model of Bietti crystalline dystrophy. Lockhart CM; Nakano M; Rettie AE; Kelly EJ Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5572-81. PubMed ID: 25118264 [TBL] [Abstract][Full Text] [Related]
12. Identification of CYP4V2 mutation in 36 Chinese families with Bietti crystalline corneoretinal dystrophy. Yin X; Yang L; Chen N; Cui H; Zhao L; Feng L; Li A; Zhang H; Ma Z; Li G Exp Eye Res; 2016 May; 146():154-162. PubMed ID: 26971461 [TBL] [Abstract][Full Text] [Related]
13. [Generation and characterization of Jia RX; Jiang SW; Zhao L; Yang LP Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1099-1106. PubMed ID: 34916689 [TBL] [Abstract][Full Text] [Related]
14. A novel and efficient murine model of Bietti crystalline dystrophy. Wang Y; Liu Y; Liu S; Li X; Liu X; Jiao M; Yang Y; Luo X; Wang F; Wan X; Sun X Dis Model Mech; 2022 Mar; 15(3):. PubMed ID: 35230417 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal characterisation of function and structure of Bietti crystalline dystrophy: report on a novel homozygous mutation in Lockhart CM; Smith TB; Yang P; Naidu M; Rettie AE; Nath A; Weleber R; Kelly EJ Br J Ophthalmol; 2018 Feb; 102(2):187-194. PubMed ID: 28698241 [TBL] [Abstract][Full Text] [Related]
16. A Bietti Crystalline Dystrophy Mouse Model Shows Increased Sensitivity to Light-Induced Injury. Ma Z; Jiao X; Agbaga MP; Anderson RE; Qian H; Li Q; Dong L; Hejtmancik JF Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361898 [TBL] [Abstract][Full Text] [Related]
17. Treating Bietti crystalline dystrophy in a high-fat diet-exacerbated murine model using gene therapy. Qu B; Wu S; Jiao G; Zou X; Li Z; Guo L; Sun X; Huang C; Sun Z; Zhang Y; Li H; Zhou Q; Sui R; Li W Gene Ther; 2020 Aug; 27(7-8):370-382. PubMed ID: 32483213 [TBL] [Abstract][Full Text] [Related]
18. Identification of novel CYP4V2 genotypes associated with Bietti crystalline dystrophy and atypical anterior segment phenotypes in Spanish patients. García-García GP; Martínez-Rubio M; Moya-Moya MA; Pérez-Santonja JJ; Escribano J Acta Ophthalmol; 2018 Nov; 96(7):e865-e873. PubMed ID: 29691984 [TBL] [Abstract][Full Text] [Related]
19. A novel mutation in the CYP4V2 gene in a Chinese patient with Bietti's crystalline dystrophy. Song Y; Mo G; Yin G Int Ophthalmol; 2013 Jun; 33(3):269-76. PubMed ID: 23242590 [TBL] [Abstract][Full Text] [Related]
20. New compound heterozygous CYP4V2 mutations in bietti crystalline corneoretinal dystrophy. Wang T; Chen Q; Yao X; Kuang L; Gan R; Wang J; Yan X Gene; 2021 Jul; 790():145698. PubMed ID: 33964374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]